|
28/11/2016 |
NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer |
CIM |
Registered |
|
30/04/2017 |
Nimotuzumab-pancreatic cancer-adults-Phase IV. |
CIM |
Registered |
|
05/10/2018 |
Nimotuzumab cold kit for the immunodiagnosis of solid tumors |
CIM |
Registered |
|
03/08/2018 |
CIMAvax-EGF-Platelets-Adults- Lung Cancer |
CIM |
Registered |
|
17/10/2018 |
CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial |
CIM |
Registered |
|
08/08/2018 |
VSSP in metastasic renal cell carcinoma |
CIM |
Registered |
|
09/07/2018 |
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory |
CIM |
Registered |
|
02/08/2018 |
NeuroEPO in stroke |
CIM |
Registered |
|
28/12/2018 |
Nimotuzumab in Non-Small Cell Lung Cancer (NSCLC) of inoperable stage III epidermoid histology, concomitant with Chemo and Radiotherapy (CRT) |
CIM |
Registered outdated |
|
22/10/2020 |
CIMAvax-EGF in patients at high risk of lung cancer |
CIM |
Registered outdated |
|
11/08/2020 |
CIMAvax-EGF in Bladder cancer |
CIM |
Registered outdated |
|
01/10/2020 |
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. |
CIM |
Registered outdated |
|
19/11/2020 |
NeuroEPO-Ataxia-Adults-Phase III |
CIM |
Registered outdated |
|
11/03/2021 |
Phyisician Led CIMAvax-EGF lung biomarkers |
CIM |
Registered outdated |
|
18/03/2021 |
Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adults |
CIM |
Registered outdated |
|
26/03/2021 |
Itolizumab Safety and Efficacy Study in Covid 19 |
CIM |
Registered |
|
08/04/2021 |
VSSP in renal cell carcinoma |
CIM |
Registered |
|
18/06/2021 |
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM) |
CIM |
Registered outdated |
|
21/05/2021 |
Preventive use of CIMAvax-EGF in patients at high risk of lung cancer. PREVAX |
CIM |
Registered outdated |
|
22/05/2021 |
Safety and efficacy of CIMAvax®-EGF in combination with tyrosine kinase inhibitors in patients with advanced stage Non-Small Cell Lung Cancer and EGFR mutations |
CIM |
Registered outdated |
